Login to Your Account

Top 5 Firms Control 70%

Biologics Manufacturing Grows, But Small Firms Won't Benefit

By Nuala Moran
BioWorld Today Correspondent

Tuesday, December 6, 2011
GLASGOW, SCOTLAND – The global capacity for manufacturing biologics is growing, but most facilities are controlled by a few major companies and used for their own products, creating difficulties for smaller biotechs with products that are approaching commercialization.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription